404 related articles for article (PubMed ID: 35644529)
21. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
[TBL] [Abstract][Full Text] [Related]
22. Renal drug transporters and their significance in drug-drug interactions.
Yin J; Wang J
Acta Pharm Sin B; 2016 Sep; 6(5):363-373. PubMed ID: 27709005
[TBL] [Abstract][Full Text] [Related]
23. Enantioselective Drug Recognition by Drug Transporters.
Uwai Y
Molecules; 2018 Nov; 23(12):. PubMed ID: 30467304
[TBL] [Abstract][Full Text] [Related]
24. Membrane transporter proteins: a challenge for CNS drug development.
Girardin F
Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
[TBL] [Abstract][Full Text] [Related]
25. Transporters and drug-drug interactions: important determinants of drug disposition and effects.
König J; Müller F; Fromm MF
Pharmacol Rev; 2013 Jul; 65(3):944-66. PubMed ID: 23686349
[TBL] [Abstract][Full Text] [Related]
26. Species differences in drug transporters and implications for translating preclinical findings to humans.
Chu X; Bleasby K; Evers R
Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):237-52. PubMed ID: 23256482
[TBL] [Abstract][Full Text] [Related]
27. Expression analysis of human solute carrier (SLC) family transporters in nasal mucosa and RPMI 2650 cells.
Dolberg AM; Reichl S
Eur J Pharm Sci; 2018 Oct; 123():277-294. PubMed ID: 30041030
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibition of human solute carrier transporters by multikinase inhibitors.
Johnston RA; Rawling T; Chan T; Zhou F; Murray M
Drug Metab Dispos; 2014 Nov; 42(11):1851-7. PubMed ID: 25165131
[TBL] [Abstract][Full Text] [Related]
29. Expression and function of organic cation and anion transporters (SLC22 family) in the CNS.
Farthing CA; Sweet DH
Curr Pharm Des; 2014; 20(10):1472-86. PubMed ID: 23789957
[TBL] [Abstract][Full Text] [Related]
30. Putative roles of organic anion transporting polypeptides (OATPs) in cell survival and progression of human cancers.
Nakanishi T; Tamai I
Biopharm Drug Dispos; 2014 Nov; 35(8):463-84. PubMed ID: 25156339
[TBL] [Abstract][Full Text] [Related]
31. The inhibitory effects of eighteen front-line antibiotics on the substrate uptake mediated by human Organic anion/cation transporters, Organic anion transporting polypeptides and Oligopeptide transporters in in vitro models.
Lu X; Chan T; Zhu L; Bao X; Velkov T; Zhou QT; Li J; Chan HK; Zhou F
Eur J Pharm Sci; 2018 Mar; 115():132-143. PubMed ID: 29307856
[TBL] [Abstract][Full Text] [Related]
32. Organic Anion Transporter 2: An Enigmatic Human Solute Carrier.
Shen H; Lai Y; Rodrigues AD
Drug Metab Dispos; 2017 Feb; 45(2):228-236. PubMed ID: 27872146
[TBL] [Abstract][Full Text] [Related]
33. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
[TBL] [Abstract][Full Text] [Related]
34. Drug Transport by the Blood-Aqueous Humor Barrier of the Eye.
Lee J; Pelis RM
Drug Metab Dispos; 2016 Oct; 44(10):1675-81. PubMed ID: 26895982
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein.
Knop J; Misaka S; Singer K; Hoier E; Müller F; Glaeser H; König J; Fromm MF
PLoS One; 2015; 10(10):e0139370. PubMed ID: 26426900
[TBL] [Abstract][Full Text] [Related]
36. SLC22, SLC44, and SLC47 transporters--organic anion and cation transporters: molecular and cellular properties.
Pelis RM; Wright SH
Curr Top Membr; 2014; 73():233-61. PubMed ID: 24745985
[TBL] [Abstract][Full Text] [Related]
37. Role of OATP transporters in the disposition of drugs.
Niemi M
Pharmacogenomics; 2007 Jul; 8(7):787-802. PubMed ID: 18240907
[TBL] [Abstract][Full Text] [Related]
38. Renal organic anion transporters in drug-drug interactions and diseases.
Huo X; Liu K
Eur J Pharm Sci; 2018 Jan; 112():8-19. PubMed ID: 29109021
[TBL] [Abstract][Full Text] [Related]
39. Solute carrier transporters: potential targets for digestive system neoplasms.
Xie J; Zhu XY; Liu LM; Meng ZQ
Cancer Manag Res; 2018; 10():153-166. PubMed ID: 29416375
[TBL] [Abstract][Full Text] [Related]
40. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
Bachmakov I; Glaeser H; Fromm MF; König J
Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
